Kits Segment to Hold Largest Market Share During 2022–2028
According to our new research study on "GMP Cell Therapy Consumables Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Cell Therapy, Process, and End Use," the market was valued at US$ 11,031.25 million in 2021 and is likely to reach US$ 59,985.89 million by 2028; it is estimated to grow at a CAGR of 27.5% during 2022–2028.
The report highlights the trends and drivers prevailing in the market. Rise in research & development and drug discovery and increase in strategic collaborations among the companies are among the major factors driving the market growth. However, stringent regulatory policies hamper the market growth.
The GMP cell therapy consumables market, by product, is segmented into kits, reagents/molecular biology reagents, cell culture media and supplements, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. The kits segment held the largest market share in 2021. However, the growth factors/cytokines and interleukins segment is anticipated to register the highest CAGR during the forecast period. Based on cell therapy, the global GMP cell therapy consumables market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. The T-cell therapy segment held the largest share of the market in 2021. However, the NK cell therapy segment is expected to register the highest CAGR during the forecast period. The GMP cell therapy consumables market, by end use, is segmented into clinical, commercial, and research. The clinical segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. The GMP cell therapy consumables market, by process, is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/ quality assurance, and others. The cell collection and characterization/sorting and separation segment held the largest share of the market in 2021. However, the cryopreservation segment is anticipated to register the highest CAGR in the market during the forecast period.
GMP Cell Therapy Consumables Market, by Process (%)
GMP Cell Therapy Consumables Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
GMP Cell Therapy Consumables Market Size & Growth | 2028
Download Free Sample
Source: The Insight Partners Analysis
Impact of COVID-19 Pandemic on GMP Cell Therapy Consumables Market
Countries across the world witnessed many challenges due to COVID-19 outbreak pandemic. The outbreak affected medical tourism; medical equipment, laser systems, and accessories manufacturing; and healthcare infrastructure in low-income countries. The pandemic has increased the R&D activities in the North American region for developing drugs for COVID-19 treatment and testing kits to effectively diagnose novel coronavirus infection. An increase in product launches and strategic collaborations and rise in investments in the cell therapy are likely to generate the demand for GMP cell therapy consumables in the coming years. However, the lack of funding during COVID-19 pandemic hindered the research and development of cell therapy. In a larger scenario of the pandemic, cell therapy is more expensive than other treatments, which restrained the GMP cell therapy consumables market. Considering all these factors, the impact of COVID-19 pandemic is slightly positive on the GMP cell therapy consumables market.
Sartorius AG, Thermo Fisher Scientific Inc, Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc, FUJIFILM Irvine Scientific Inc, Lonza Group AG, BPS Bioscience Inc, Merck KGaA, Global Life Sciences Solutions USA LLC, and other players in the GMP cell therapy consumables market are addressing the growing demands for GMP cell therapy consumables.
The report segments the GMP cell therapy consumables market as follows:
The GMP cell therapy consumables market is segmented on the basis of product, cell therapy, end user, and process. Based on product, the market is segmented into kits, reagents/molecular biology reagents, cell culture media and supplements, growth factors/cytokines and interleukins (including protein and nucleic acid purification buffers), and others. Based on cell therapy, the global market is segmented into NK cell therapy, stem cell therapy, T-cell therapy, and others. Based on end use, the market is segmented into clinical, commercial and research. Based on process, the GMP cell therapy consumables market is segmented into cell collection and characterization/sorting and separation, cell culture and expansion/preparation, cryopreservation, cell processing and formulation, cell isolation and activation, cell distribution/handling, process monitoring and control/readministration/ quality assurance, and others. Based on region, the GMP cell therapy consumables market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, Thailand, and Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com